# RESULTS

The board of Directors (the “Board”) of the Company is pleased to announce the unaudited condensed consolidated financial results of the Company and its subsidiaries (collectively the “Group”) for the three months ended 31 March 2020, together with the comparative figures for the corresponding period in 2019, as follows.

# QUARTERLY CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

# FOR THE THREE MONTHS ENDED 31 MARCH 2020

<table><tr><td rowspan="3"></td><td rowspan="3">Notes</td><td colspan="2">(Unaudited)
Three months ended
31 March</td></tr><tr><td>2020</td><td>2019</td></tr><tr><td>RMB’000</td><td>RMB’000</td></tr><tr><td>Revenue</td><td>3</td><td>60,717</td><td>71,103</td></tr><tr><td>Cost of sales</td><td></td><td>(47,795)</td><td>(52,784)</td></tr><tr><td>Gross profit</td><td></td><td>12,922</td><td>18,319</td></tr><tr><td>Other income</td><td>4</td><td>5,262</td><td>8,181</td></tr><tr><td>Selling and marketing expenses</td><td></td><td>(10,385)</td><td>(12,344)</td></tr><tr><td>Administrative expenses</td><td></td><td>(8,092)</td><td>(12,443)</td></tr><tr><td>Share-based compensation expense</td><td></td><td>—</td><td>(2,146)</td></tr><tr><td>Research and development expenses</td><td></td><td>(2,689)</td><td>(6,295)</td></tr><tr><td>Finance costs</td><td>5</td><td>(1,196)</td><td>(2,390)</td></tr><tr><td>Net impairment loss on financial and contract assets</td><td></td><td>(13,710)</td><td>(7,436)</td></tr><tr><td>Share of profit of joint ventures</td><td></td><td>(2,230)</td><td>—</td></tr><tr><td>Loss before income tax</td><td>5</td><td>(20,118)</td><td>(16,554)</td></tr><tr><td>Income tax credit/(expense)</td><td>6</td><td>2,056</td><td>2,635</td></tr><tr><td>Loss for the period</td><td></td><td>(18,062)</td><td>(13,919)</td></tr><tr><td>Other comprehensive loss</td><td></td><td></td><td></td></tr><tr><td>Items that may be subsequently reclassified 
 to profit or loss:</td><td></td><td></td><td></td></tr><tr><td> Exchange difference arising on the translation 
    of foreign operation</td><td></td><td>(4,825)</td><td>(9,036)</td></tr><tr><td>Total comprehensive loss for the period</td><td></td><td>(22,887)</td><td>(22,955)</td></tr></table>

<table><tr><td rowspan="3"></td><td rowspan="3">Notes</td><td colspan="2">(Unaudited)
Three months ended
31 March</td></tr><tr><td>2020</td><td>2019</td></tr><tr><td>RMB’000</td><td>RMB’000</td></tr><tr><td>Loss for the period attributable to:</td><td></td><td></td><td></td></tr><tr><td>Equity holders of the Company</td><td></td><td>(18,266)</td><td>(13,796)</td></tr><tr><td>Non-controlling interests</td><td></td><td>204</td><td>(123)</td></tr><tr><td></td><td></td><td>(18,062)</td><td>(13,919)</td></tr><tr><td>Total comprehensive loss
 for the period attributable to:</td><td></td><td></td><td></td></tr><tr><td>Equity holders of the Company</td><td></td><td>(23,091)</td><td>(22,832)</td></tr><tr><td>Non-controlling interests</td><td></td><td>204</td><td>(123)</td></tr><tr><td></td><td></td><td>(22,887)</td><td>(22,955)</td></tr><tr><td>Loss per share for profit attributable to equity
 holders of the Company
 (expressed in RMB cents per share)</td><td>8</td><td></td><td></td></tr><tr><td> Basic</td><td></td><td>(2.87)</td><td>(2.21)</td></tr><tr><td> Diluted</td><td></td><td>(2.87)</td><td>(2.21)</td></tr></table>